PLx Pharma Inc. (PLXP) financial statements (2021 and earlier)

Company profile

Business Address 9 FISHERS LANE
SPARTA, NJ 07871
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:22141424173227
Cash and cash equivalents2214142417527
Short-term investments     27 
Other undisclosed cash, cash equivalents, and short-term investments    0(0) 
Receivables 000   
Inventory, net of allowances, customer advances and progress billings0(1)(1)0   
Inventory0(1)(1)0   
Prepaid expense  00000
Deferred costs0 0    
Deposits current assets   0   
Other undisclosed current assets0111(0)0 
Total current assets:23141526173227
Noncurrent Assets
Operating lease, right-of-use asset01
Property, plant and equipment1111   
Intangible assets, net (including goodwill), including:2222   
Goodwill2222   
Intangible assets, net (excluding goodwill)   2   
Other undisclosed intangible assets, net (including goodwill)   (2)   
Deposits noncurrent assets0000   
Other noncurrent assets    000
Total noncurrent assets:4443000
TOTAL ASSETS:27191829173227
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1111221
Accrued liabilities    100
Employee-related liabilities    111
Interest and dividends payable100    
Other undisclosed accounts payable and accrued liabilities0111111
Debt143    
Other liabilities0000   
Other undisclosed current liabilities2111   
Total current liabilities:4652221
Noncurrent Liabilities
Long-term debt and lease obligation 147   
Long-term debt, excluding current maturities 147   
Liabilities, other than long-term debt109315   
Other liabilities0000   
Derivative instruments and hedges, liabilities108315   
Other undisclosed noncurrent liabilities3200   
Total noncurrent liabilities:1311722   
Total liabilities:16171224221
Stockholders' equity
Stockholders' equity attributable to parent(11)(12)65153126
Common stock0000000
Additional paid in capital91757372777248
Accumulated deficit(102)(87)(66)(67)(62)(41)(22)
Other undisclosed stockholders' equity2114     
Total stockholders' equity:10265153126
TOTAL LIABILITIES AND EQUITY:27191829173227

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0111   
Revenue, net1   
Sublease income00
Cost of revenue
(Cost of Goods and Services Sold)
  (1)(0)   
Gross profit:01(0)0   
Operating expenses(13)(15)(12)(17)(21)(19)(14)
Other undisclosed operating income (loss)(0) 10   
Operating loss:(13)(14)(11)(16)(21)(19)(14)
Nonoperating income (expense)(2)012(0)   
Investment income, nonoperating 000   
Interest and debt expense(0)(1)(1)(1)   
Loss from continuing operations before equity method investments, income taxes:(16)(15)(0)(17)(21)(19)(14)
Other undisclosed income (loss) from continuing operations before income taxes0(6)11   
Income (loss) from continuing operations before income taxes:(15)(21)1(16)(21)(19)(14)
Income tax expense (benefit)(4)(9)(2)1   
Net loss:(20)(29)(1)(15)(21)(19)(14)
Other undisclosed net income attributable to parent492 00 
Net income (loss) attributable to parent:(15)(21)1(15)(21)(19)(14)
Preferred stock dividends and other adjustments(2)(14)     
Net income (loss) available to common stockholders, diluted:(17)(34)1(15)(21)(19)(14)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(20)(29)(1)(15)(21)(19)(14)
Comprehensive loss, net of tax, attributable to parent:(20)(29)(1)(15)(21)(19)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: